University of Calgary
UofC Navigation

Mark Hamilton


Professor, Department of Clinical Neurosciences

(403) 955-7805

Alberta Children's Hospital
2888 Shaganappi Tr, NW
Calgary, AB  T3B 6A8


Dr. Hamilton graduated from McGill University Medical School in 1983. He did his Neurosurgery Residency at the University of Calgary and received his FRCSC in 1991. He did Fellowship training in cerebrovascular, skull base and pediatric Neurosurgery at the Barrow Neurological Institute in Phoenix, Arizona and joined the University of Calgary Department of Clinical Neurosciences in 1994 where he is currently a Professor of Neurosurgery with additional appointments in the Department of Surgery and the Department of Pediatrics. He was the Chief of the Division of Pediatric Neurosurgery from 2002-2011 and is the current Director of the Neurosurgical Oncology Program. Dr. Hamilton established the University of Calgary Adult Hydrocephalus Program and started the University of Calgary Adult Hydrocephalus Clinic in 2008. Dr. Hamilton is the chair of the Adult Hydrocephalus Clinical Research Network (AHCRN), Secretary-Treasurer of the International Society for Hydrocephalus and Cerebrospinal Fluid Disorders (ISHCSF) and a member of the Board of Directors of the Hydrocephalus Association (HA) and the Medical Advisory Board (MAB) of HA. He was recently the Congress President for “Hydrocephalus 2015” the 7th annual meeting of the ISHCSF. In addition, he is a member of the Board of Directors of the Canadian Brain Tumor Consortium (CBTC). His main clinical and research interests are the diagnosis and management of hydrocephalus in adults and clinical trials in management of patients with malignant brain tumors.

Research Activities: 

Assessing treatment for patients with malignant brain tumors

Other Area(s) of Research:

Prevention of venous thromboembolism in brain tumor patients

Research Interests:

Current research interests include clinical trials assessing treatment for patients with malignant brain tumors, and the prevention of venous thromboembolism in brain tumor patients.

  • M.D. (Doctor of Medicine)